Business : Biotech Veteran Peter Olagunju Joins ImmunoScape As CEO
KUALA LUMPUR, Sept 24 (Bernama) -- ImmunoScape Pte Ltd, an A*STAR spin-out developing T-cell receptor (TCR)-based cancer immunotherapies, has appointed biotechnology industry veteran Peter Olagunju as chief executive officer (CEO) to guide its "Seed and Boost" platform towards clinical development.
We haven't written up this one. Bernama has the full story — the link below goes straight to it.